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Background & objectives: Dengue virus  (DV) has caused severe epidemics of dengue fever (DF) and
dengue haemorrhagic fever (DHF) and is endemic all over India. We have earlier reported that
exposure of mice to hexavalent chromium [Cr(VI)] compounds increased the severity of dengue
virus infection. Trivalent chromium picolinate (CrP) is used worldwide as micronutrient and
nutritional supplement. The present study was therefore, carried out to investigate the effects of
CrP on various haematological parameters during DV infection of mice.
Methods: The Swiss Albino smice were inoculated with dengue virus (1000 LD50, intracerebrally)
and fed with chromium picolinate (CrP) in drinking water (100 and 250 mg/l) for 24 wk. Peripheral
blood leucocytes and other haematological parameters, and spleens were studied on days 4 and 8
after virus inoculations and the findings were compared with those given only CrP and the normal
control age matched mice.
Results: CrP in drinking water for 24 wk had no significant effects on peripheral blood cells of mice.
On the other hand, there was significant decrease in different haematological parameters following
inoculation of normal mice with DV. In CrP fed mice the effects of DV infection were abolished on
most of the haematological parameters.
Interpretation & conclusions: The findings of present study showed that the adverse effects of DV
infection, specially on platelets and leucocytes, were abrogated by pretreatment of mice with CrP.
The therapeutic utility of CrP in viral infections including dengue needs to be studied in depth.
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Dengue virus (DV) produces a benign self-limiting
illness, the dengue fever (DF) or a life-threatening
serious illness, the dengue haemorrhagic fever (DHF).
Dengue virus is endemic in India with frequent
epidemics of DF and DHF1-6. The dengue disease is
characterized by leucopenia, thrombocytopenia, bone
marrow suppression, increased haematocrit value and
increased capillary permeability, which may result in
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haemorrhage and shock7-9. Immunopathological
mechanisms appear to be responsible for the
pathogenesis of DHF. A rapid increase in the levels of
cytokines and chemical mediators apparently induced
by a unique cytokine, cytotoxic factor (CF), plays a key
role in inducing plasma leakage, shock and
haemorrhagic manifestations10,11.
Pollution of environment by chromium (Cr) is
common in industrialized areas as a consequence of
effluent discharge from tanneries and other industries,
which include metal plating, manufacturing industries
and ferrochrome production. This poses serious problem
for environmental quality. In aqueous environments
chromium has two oxidation states: hexavalent
chromium (Cr-VI) and trivalent chromium (Cr-III). Cr
(VI) compounds are generally soluble over a wide pH
range and have been shown to exert toxic and
carcinogenic effects in humans and experimental
animals, also induce DNA damage such as DNA single-
strand breaks and DNA-protein crosslinks in vivo and
in cultured cells. On the other hand, Cr (III) compounds
are mainly non-toxic12-15 .
DV infection is endemic all over India, so is the
occupational and non occupational exposure to Cr (VI).
The effect of chromium compromises the immune
response of the host16,17. It is, therefore, possible that
the chromium toxicity may adversely affect the disease
process during DV infection. In our earlier study we
have reported that Cr (VI) in the form of potassium
dichromate drinking led to reduction in lymphocytes,
haemoglobin and the haematocrit values while the
granulocyte, monocyte and platelet counts were
increased. The most significant finding of these
experiments was that the DV-induced reduction of
platelet counts was cancelled in Cr (VI)-fed mice18.
Chromium picolinate monohydrate, (CrP) is a
synthetic Cr (III) compound that has widespread use as
a nutritional supplement. It promotes a variety of
beneficial health effects including weight loss, serum
cholesterol reduction, treatment of diabetes, and
increased muscle mass19. CrP administered to mice in
the diet for 3 months up to the maximal possible dose
(approximately 20,000-30,000 times that of the average
daily human supplement 200 - 400 µg) to show any
adverse effects20-23. No effects of CrP exposure on
clinical chemistry or haematology parameters, gross
lesions, or microscopic findings have been observed24-26.
We, therefore, undertook this study to investigate the
effects of dengue virus infection in mice fed with non
toxic trivalent chromium in the from of chromium
picolinate (CrP).
Material & Methods
Animals: The study was carried out on Swiss Albino
mice weighing 25-30 g, aged 6-8 wk obtained from the
animal breeding facility of the Industrial Toxicology
Research Centre (ITRC), Lucknow. Study protocol was
approved by the Animal Ethical Committee of the ITRC,
Lucknow. Mice were maintained on pellet diet supplied
by local supplier.
Dengue virus: Dengue type 2 virus, strain P23085
(received from National Institute of Virology, Pune) was
used in the form of infected infant mouse brain
suspension. Mice were given light ether anaesthesia and
then inoculated with 1000 LD50 of DV intracerebrally(ic) in volume of 30 µl.
CrP treatment: Mice were divided in three groups of
18 animals each. One group was given ad libitum
drinking water containing 100 mg/l chromium
picolinate, second group was given drinking water
containing 250 mg/l chromium picolinate and third
group (control) was given plain water to drink. After
24 wk of CrP drinking, 12 animals in each group were
inoculated i.c. with dengue virus in doses of 1000 LD50.
The mice were scarificed by cervical dislocation the 4th
(6 animals, clinical signs of illness appear) and 8th (6
animals, paralysis of hind limbs set in) day post virus
inoculation (pi).
Haematological study: Animals were sacrificed and 1.5
ml blood was collected from the jugular vein in tubes
with 0.1 ml freshly prepared 10 per cent K3 EDTA
solution as anticoagulant. The samples were shaken
gently. The following estimations were performed
immediately with the help of a fully automatic
haematology analyzer (Bayer; Technicon H1*E,
Germany): total leucocyte count (TLC), differential
leucocyte count (DLC), total RBC count, haematocrit
(Hct), haemoglobin (Hb), mean corpuscular volume
(MCV) and platelet counts.
Preparation of spleen cell culture: The spleen cells were
teased out in cold minimal essential medium (MEM,
Hi-Media, Mumbai) and a single cell suspension was
prepared. The viable nucleated cell count as ascertained
by trypan blue dye exclusion test27 was more than 95
per cent.
Spleen cell proliferation assay28: The cell suspension
of normal mice spleen was adjusted to 2x106 cells/ml
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in Eagle’s MEM supplemented with 10 per cent foetal
calf serum. Cell cultures were set up in 96 wells U-
bottom microtitre plates in triplicate. Each well
contained 0.2 ml cell suspension with or without 5 µg/
ml concanavalin A (Con A). The cultures were incubated
for 72 h at 37oC in presence of 5 per cent CO2. Five
hours before the termination of the cultures, 20 µl of
MTT3-(4,5-dimethyl thiazole-2-yl)-2,5-diphenyl
tetrazolium bromide (5mg/ml PBS, phosphate buffer
saline) was added to each well. Cells were harvested
and supernatant discarded and 200 µl of dimethyl
sulfoxide was added; readings were recorded after 10
min at 570 nm using 630 nm as reference OD. All the
chemicals used were procured from Sigma, USA.
Preparation of spleen homogenate: Spleens were
washed free of blood, homogenized in a tissue
homogenizer giving a 10 per cent solution (w/v) in
chilled PBS (pH 7.2). The homogenate was centrifuged
in the cold at 8000 g for 10 min and clear supernatant
was stored in small aliquots at -20oC. Normal mouse
spleen homogenates were prepared similarly and used
as control.
Cytotoxicity test: Cytotoxic factor (CF) is present in
the homogenates prepared from the DV-infected mouse
spleen and has the capacity to kill normal mouse spleen
cells in one hour time. The cytotoxic activity of the
spleen homogenate isolated from DV infected mice was
tested using normal mouse spleen cells as target. The
test was carried out in 96 wells plates, using 0.1 ml
volume of each preparation. The target single cell
suspension of normal mouse spleen was prepared. Then
the cell viability was measured by MTT assay. The MTT
assay was done in triplicate and the mean value of % of
non-viable cell as obtained in repeated experiments are
presented24. All procedures were carried out at 4oC in
ice bath.
Statistical analysis: Two-way analysis of variance (Two-
way ANOVA) was done by Systat Software, Inc. (USA),
to compare the mean values of the outcome variables
considering chromium exposure and dengue virus
infection to animals as independent variables. Prior to
this homogeneity of variance between the treated groups
were ascertained. The two-group comparison was done
by calculating least significant difference at 5 per cent
level of significance.
                                            Results
Effect CrP feeding on blood cells during DV infection:
Effects on leucocytes: In normal control mice the total
leucocyte count was 11.5+4.6x103/cubic millimeter (Cu
mm) with 87 per cent lymphocytes and about 9
per cent granulocytes. By giving CrP (100mg/l and
250mg/l) in drinking water for 24 wk the total as well
as differential leucocyte counts were not affected
significantly (Table I).  In the normal mice DV infection
caused a significant reduction in the total leucocyte at
day 4 (P<0.05) and 8 (P<0.01) compared to uninfected
mice. The predominant cells in the blood remained
lymphocytes in all the groups (Table I).
Effects on red blood cells: Feeding CrP had no effect
on the red blood cell count, haemoglobin and MCV,
where as haematocrit concentration was significantly
increased at 250 mg/l dose of CrP  (P<0.05) (Table II).
Normal mice inoculated with DV showed reduced total
RBC counts (P<0.01), haematocrit (P<0.05) and
haemoglobin (P<0.05) at day 8 of DV inoculation
(Table II). In CrP fed mice DV inoculation caused no
significant change in these indices.
Effect on platelet count: The platelet count in the blood
of normal control mice was 406 ± 81×106/Cu mm,
whereas after 100 mg/l CrP drinking it significantly
increased to 484 ± 51 x106/Cu mm (P<0.05) but with
250 mg/l CrP feeding count was slightly decreased to
366 ± 52×106/µl compared to normal controls. When
normal control mice were inoculated with the dengue
virus, a significant reduction in the platelet count was
seen on  days 4 and 8 being 179 ± 57 ×106 (P<0.001)
and 312 ± 51x106 (P=<0.01) respectively. In CrP fed
mice DV inoculation caused no significant change
(Fig. 1).
Fig. 1. Effects of CrP feeding (24 wk) on platelet count during
dengue virus infection. CrP, chromium picolinate; DV, dengue virus;
4, 8, days after the virus infection compared to controls. (n=6 in
each group). Values are mean ± SD.
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Table I. Leucocytes count in cromium picolinate fed mice after dengue virus (DV) infection
CrP treated TLC (103/Cu mm) Lymphocytes (%) Granulocytes (%) Monocytes (%)
groups
Control DV4d DV8d Control DV4d DV8d Control DV4d DV8d Control DV4d DV8d
Normal 11.5 ± 4.6 8.0 ± 3.2* 5.8 ± 2.3** 87 ± 1.9 82 ± 6.0 80 ± 3.0 9.5 ± 1.8 14 ± 5.6 15 ± 1.4** 3.3 ± 0.3 4.0 ± 0.8 4.5 ± 0.9
100ppm CrP 10.8 ± 1.5 10.5 ± 2.1 9.7 ± 3.0 90 ± 3.5 88 ± 3.5 82 ± 0.5 8.0 ± 2.9 8.0 ± 2.7 12 ± 1.0* 2.3 ± 0.6 3.9 ± 0.8 6.0 ± 0.6
250ppm CrP 11.2 ± 2.3 10.8 ± 0.3 9.3 ± 1.2 86 ± 6.0 85 ± 1.0 87 ± 9.0 10 ± 3.0 11 ± 1.0 12 ± 1.7* 3.2 ± 1.5 4.1 ± 3.2 3.3 ± 1.1
Control, normal mice; DV4d, 4th day after infection DV; DV8d, 8th day after infection with DV; TLC, total leucocyte count
Values are mean ± SD of 6 animals in each group
P*<0.05; ** <001 compared to normal
Table II. RBC indices  in cromium picolinate  fed mice after dengue virus (DV) infection
CrP treated RBC (106/Cu mm) Hb (g/l) HCt (%) MCV (fl)
groups
Control DV4d DV8d Control DV4d DV8d Control DV4d DV8d Control DV4d DV8d
Normal 8.8 ± 0.5 6.2 ± 0.3 5.9 ± 0.5** 14 ± 1.9 11 ± 0.8 9.0 ± 1.2* 29 ± 3.8 21 ± 2.0 23 ± 2.3* 36 ± 1.7 37 ± 2.3 34 ± 1.8
100ppm CrP 8.0 ± 0.5 7.3 ± 1.2 7.7 ± 1.0 14 ± 0.9 15 ± 0.9 13 ± 2.5 29 ± 3.3 26 ± 5.6 31 ± 4.5 36 ± 2.2 36 ± 2.7 37 ± 1.2
250ppm CrP 8.7 ± 0.6 7.7 ± 1.7 7.6 ± 0.5 16 ± 0.9 14 ± 3.4 14 ± 0.9 37 ± 1.0* 31 ± 0.7 30 ± 2.5 39 ± 2.7 35 ± 3.5 37 ± 1.7
Control, normal mice; DV4d, 4th day after infection with DV; DV8d, 8th day after infection with DV; RBC, red blood cell; MCV, mean corpuscular volume;
HCt, haematocrit; Hb, haemoglobin
P* <0.01 **<0.01 compared to control
+
 P<0.05 compared to control of normal unfed group
Value are mean ± SD of 6 animals in each group
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Effect on weight of spleen: The weight of the spleen in
the control normal mice was 477 ± 59 mg/100 g body
weight. Significant reduction in the weight of the spleen
with 100 mg/l CrP was observed [388 ± 55 mg/100 g
(P<0.05) body weight] whereas with 50 mg/l CrP it was
increased significantly (P<0.05) being (587+79 mg/
100g). The weight of the spleen of normal mice
inoculated with DV was 439 ± 30 and 340 ± 25mg/
100 g body weight on day 4 and 8 post-inoculation,
respectively  (Figs 2 & 3). When CrP treated mice were
inoculated with DV, only with 250 mg/l CrP dose a slight
protection was observed against DV induced reduction
in spleen weight in comparison to DV alone.
Effects on production of cytotoxic factor (CF): The
homogenate from DV-infected mice spleen produced
13 to 25 per cent cytotoxicity (Fig. 4). On the other
hand, no cytotoxic activity was seen in the spleen homogenates obtained from CrP fed mice in comparison
to normal control mice. A significant decrease (P
<0.001) in cytotoxic activity of spleen homogenate of
DV infected mice was observed after pretreatment with
CrP at both doses.
Effect on mitogenic stimulation: When normal mice
spleen cells were treated with mitogen the observed
stimulation was 0.171 + 0.05. When normal mice were
inoculated with DV, maximum proliferation occurred
at the fourth day (0.375 ± 0.030) and it was suppressed
significantly on day 8 (P<0.05). On the other hand, after
24 wk of drinking of 100 mg/l CrP, spleen cell
proliferation in mice increased by two-fold of normal
mice spleen cells. When CrP (100 mg/l) fed mice were
inoculated with DV, on day 8 of infection there was no
DV induced suppression in mitogenic stimulation in
comparison to the DV alone mice group.
Discussion
The present study showed abrogation of DV-
induced adverse effects on different haematological
parameters in mice after feeding CrP for 24 wk. The
characteristic leucopenia, thrombocytopenia and
increased haematocrit are common findings in clinical
dengue disease and together with combination of
clinical picture are  used as markers for early diagnosis
of dengue infection7,9,29,-31. Constant haematological
abnormalities occurring in severe dengue disease
include bone marrow suppression32. La Russa & Innis33
have reviewed data from experimental dengue
infections of volunteers and bone marrow studies from
patients with severe dengue virus infection which
showed that marrow suppression evolves rapidly
through several phases and recovers. The early blast
Fig. 2. Effects of  CrP on spleen weight (in mg/100g body weight)
during dengue virus infection. CrP, chromium picolinate; DV 4, 8
d, dengue virus 4, 8, days after the virus infection compared to
controls. Values are mean ± SD of n=6 mice in each group.
Fig. 3. Cytotoxic activity of the homogenates of spleens obtained
from various groups of mice. Values are mean ± SD of n=6 mice in
each group.
Fig. 4. Effects of CrP feeding on mitogenic stimulation of spleen
cells during dengue virus infection. Value are mean ± SD (n=6).
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cells and the differentiated haematopoietic elements are
abortively infected, killed and eliminated by
phagocytosis by specialized marrow dendritic cells.
Cytokine production by virus-infected stromal cells is
also altered33. The combined effect of these changes is
transient bone marrow suppression resulting in
leucopenia and thrombocytopenia.
Our present findings are supported by those on
human subjects that the haematocrit, haemoglobin, RBC
count, MCV, MCH, MCHC, red blood cell distribution
width, platelet count, and mean platelet volume are
within normal clinical ranges and are unchanged by
chromium picolinate supplementation for 12 wk28.
Recent studies35,36 demonstrate that chromium picolinate
supplementation significantly improves insulin
sensitivity and glucose control in subjects with type 2
diabetes and also in obese subjects with polycystic ovary
syndrome.
In this study haemoglobin concentration and the
haematocrit value  decreased day 8 after DV inoculation
in normal mice. Pimpan & Prasert7 reported that in
patients with DHF haematocrit value is increased
initially but later on it decreased. On the other hand,
DV-induced fall in RBC count, haemoglobin as well as
on haematocrit % was abolished in CrP fed mice. During
DV infection of mice a significant reduction in the
weight of the spleen occured, which was associated
with a sharp decline in the proportion of T-lymphocytes
and macrophages in the spleen27. CrP feeding had no
effect on the spleen weight of normal mice which was
similar to the findings reported by Rhodes et al26. When
CrP fed mice were inoculated with DV, a significant
protection against reduction of spleen weight
was observed on day 8 of the virus infection. Further,
the production of DV-induced cytokine, CF was
significantly reduced in CrP fed mice.
These findings showed that  the mitogenic response
of splenic lymphocytes to Con A was increased in
CrP fed mice similar to the findings reported in cows37
and in pigs fed supplemental chromium38. Organic
chromium supplements are known to increase immune
function in animals. The exact mechanism by which
chromium picolinate enhances the immune system is
not known. However, chromium supplementation has
been shown to reduce serum cortisol levels.
Glucocorticoids, which include cortisol, are known to
suppress the immune system39.
Pollution of environment by Cr (VI) poses serious
problem due to its toxicity. On the other hand, Cr (III)
compounds are mainly non-toxic16,17. We had earlier
shown that Cr (VI) drinking led to reduction of most of
the haematological parameters (except platelet counts)
enhancing the severity of dengue illness in mice40.
In conclusion, abrogation of DV-induced adverse
effects on the haematological parameters by feeding
CrP, indicates a need for in depth investigation before
it is used as supportive therapy in dengue and other
viral infections.
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